Key result
Lung cancer patients with sarcoid reaction in regional lymph nodes had a 5-year survival rate of 77.7%, which was not significantly different from patients without sarcoid reaction.
Why the study?
Are the surgical survival outcomes of lung cancer patients with sarcoid reaction in regional lymph nodes different from those without sarcoid reaction?
Cohort (n=1,733)
No
Are the surgical survival outcomes of lung cancer patients with sarcoid reaction in regional lymph nodes different from those without sarcoid reaction?
Surgical outcomes for lung cancer patients with sarcoid reaction in regional lymph nodes are not prognostically different from those without sarcoid reaction, supporting radical resection after appropriate sampling biopsy.
Answers are grounded in this paper and cite their sources.
Rare nodal sarcoid reaction in lung cancer may mimic metastasis on imaging; leaves open effects on staging accuracy and outcomes.
BACKGROUND: There have been few reports of sarcoid reaction in the regional lymph nodes associated with lung cancer. The purpose of this study was to analyze the surgical results of lung cancer with sarcoid reaction. METHODS: Of 1733 lung cancer patients undergoing surgical treatment in our institute from 1990 to 2004, we reviewed 22 patients (1.3%) with sarcoid reaction in the regional lymph nodes of lung cancer. RESULTS: On pre-operative computed tomography (CT), mediastinal lymph node swelling was detected in 19 patients (86%) as clinical N3 disease (c-N3) in six or as c-N2 in 13, while three patients were classified as c-N0. To these 19 patients, lymph node status was histologically checked by mediastinoscopy in four patients, sternotomy approach in two and open mini-thoracotomy in 13. Because the sampling-biopsy nodes showed no tumor metastasis, radical surgery was promptly performed. However, four patients (18%) were finally judged to have pathological lymph node positive disease. Five patients were in pathological stage (p-stage) IA, nine in p-stage IB, five in p-stage IIB, two in p-stage IIIA, and one in stage IIIB. The overall 3-, and 5-year survival rates of these patients were 85.2 and 77.7%, respectively, with no significant difference compared to those of the remaining patients without sarcoid reaction. CONCLUSIONS: Because lung cancer patients with sarcoid reaction in the regional lymph nodes frequently show mediastinal lymph node swelling on CT, radical resection should be performed after confirming the node status by appropriate sampling biopsy. It seems that surgical results of lung cancers with sarcoid reaction in the regional nodes are not prognostically different from those without sarcoid reaction.
No takes yet. Share an insight, caveat, or question.
Tomimaru et al. (2007) conducted a cohort in Lung cancer (n=1,733). Sarcoid reaction in regional lymph nodes vs. No sarcoid reaction was evaluated on Overall 5-year survival rate. Lung cancer patients with sarcoid reaction in regional lymph nodes had a 5-year survival rate of 77.7%, which was not significantly different from patients without sarcoid reaction.
Synapse has enriched 10 related papers. Consider them for comparative context: